PubMed COVID-19 Clinical Care
2021 - 2030 of 5967 results found
Cancer Patients' Attitudes Towards the Anti-Covid-19 Vaccine: A Collective Case Study
Description
CONCLUSION: Our study highlighted the plurality of factors that influence attitudes toward the anti-COVID-19 vaccine. It is theref+ore of fundamental importance to increase the use of the shared decision-making approach (SDM) to guide the patient to
Completion Rates and Timeliness of Diagnostic Colonoscopies for Rectal Bleeding in Primary Care
Description
CONCLUSIONS: Significant numbers of patients presenting to primary care with rectal bleeding fail to undergo recommended workup. The majority either have no procedure ordered, or procedure ordered but never scheduled or cancelled and not kept
Cesarean Delivery Outcomes for Patients with Coronavirus Disease-2019 in the USA
Description
CONCLUSIONS: CD patients with COVID-19 had 30-fold higher mortality before widespread vaccination was available with Hispanic and Medicaid patients disproportionately impacted. Potential explanations for this disparity include reduced access to
COVID-19 Outcomes in Inflammatory Bowel Disease Hospitalized Patients: A Comprehensive Analysis Using the National Inpatient Sample
Description
CONCLUSION: According to our findings, the presence of IBD does not appear to elevate the risk of COVID-19 complications.
Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS
Description
No abstract
Changes in clinical, demographic, and outcome patterns of children hospitalized with non-SARS-CoV-2 viral low respiratory tract infections before and during the COVID pandemic in Rome, Italy
Description
CONCLUSIONS: We found that the pattern of LRTI in children during COVID-19 pandemic significantly changed in terms of etiologies and increased severity.
Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron
Description
CONCLUSIONS: The emergence of E484A and E484Q prior to widespread population immunity may have been limited by fitness costs. In populations already exposed to the early immune escape epitope E484K, the Omicron founder background may have provided a